共 314 条
[1]
Meier-Kriesche HU(2006)Immunosuppression: evolution in practice and trends, 1994-2004 Am J Transplant 6 1111-1131
[2]
Li S(2000)Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Engl J Med 342 605-612
[3]
Gruessner RW(2006)Cardiovascular complications after renal transplantation and their prevention Transplantation 82 603-611
[4]
Fung JJ(2012)Progression of coronary artery calcification and thoracic aorta calcification in kidney transplant recipients Am J Kidney Dis 59 258-269
[5]
Bustami RT(2003)The natural history of chronic allograft nephropathy N Engl J Med 349 2326-2333
[6]
Barr ML(2011)Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial Lancet 377 837-847
[7]
Leichtman AB(2013)Long-term belatacept exposure maintains efficacy and safety at 5 years: results from the long-term extension of the BENEFIT study Am J Transplant 13 2875-2883
[8]
Hariharan S(2013)Incidence and impact of de novo donor-specific alloantibody in primary renal allografts Transplantation 95 410-417
[9]
Johnson CP(2007)Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2562-2575
[10]
Bresnahan BA(2010)Pharmacokinetics and pharmacodynamics of intensified versus standard dosing of mycophenolate sodium in renal transplant patients Clin J Am Soc Nephrol 5 503-511